ClinConnect ClinConnect Logo
Search / Trial NCT06017687

Data Collection and Evaluation of OptiBP Under Investigational Use

Launched by BIOSPECTAL · Aug 24, 2023

Trial Information

Current as of July 27, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking to gather information to help develop and improve a mobile phone app called OptiBP, which uses advanced technology to estimate blood pressure. By participating, you'll help researchers understand how well this app works in measuring blood pressure using a smartphone.

To join the study, you need to be at least 18 years old, live in the United States, and have an Android smartphone. You'll also need an arm-worn blood pressure cuff and be comfortable using the Google Play store to download the app. Participants should be able to communicate in English and agree to take part in the study. If you have certain medical conditions, like skin allergies to nickel or serious heart rhythm issues, you may not be eligible. If you decide to participate, you can expect to use the app and share your blood pressure readings to help improve this innovative technology.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Be at least 18 years old (at least 19 years old in Alabama and Nebraska, at least 21 years old in Puerto Rico);
  • 2. Live in the United States of America
  • 3. Have an Android smartphone
  • 4. Have access to an arm-worn blood pressure monitor (cuff)
  • 5. Have access to the Google Play store to download the OptiBP study app on their phone
  • 6. Be comfortable communicating in written and spoken English
  • 7. Be willing and able to provide informed consent to participate in the study
  • Exclusion Criteria:
  • 1. Known contact dermatitis to nickel/chromium
  • 2. Lesion or deficiency on hand, preventing placing a finger on the smartphone camera
  • 3. Known dysrhythmia like bigeminy, trigeminy, isolated VPB, atrial fibrillation

About Biospectal

Biospectal is an innovative healthcare technology company dedicated to transforming cardiovascular health through advanced optical sensing solutions. By leveraging cutting-edge algorithms and non-invasive measurement techniques, Biospectal aims to deliver accurate and real-time blood pressure monitoring and health insights directly from smartphones. Their commitment to enhancing patient care and empowering individuals with accessible health data positions them at the forefront of digital health advancements. Through rigorous clinical trials, Biospectal seeks to validate the efficacy of its solutions, ensuring they meet the highest standards of safety and reliability for patients and healthcare providers alike.

Locations

Truckee, California, United States

Patients applied

0 patients applied

Trial Officials

Frederic Frappereau

Principal Investigator

Biospectal

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported